Greater China Digest: Biomissile's Series B; Hashkey eyes funds
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.
Source: dealstreetasia.com
Stay updated with breaking news from Anji Economic Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.